Global Bioinformatics Market Analysis 2022
The Global Bioinformatics Market is expected to reach $32.65 billion by 2028 growing at a CAGR of 17.0% from 2021 to 2028. Bioinformatics is a combination of biology and information technology, that links biological data with techniques for information storage, distribution, and analysis to support multiple areas of scientific research.
Factors such as rising initiatives from private and government organizations, growing applications of bioinformatics in various industries, and rising research on molecular biology are driving the growth of the market. However, high cost is restraining the growth of the market.
Based on application, the metabolomics segment is going to have a lucrative growth during the forecast period as metabolomics generates a lot of data, and also handling, processing, and analyzing this data is an important undertaking that necessitates the use of sophisticated mathematical, statistical, and bioinformatics software.
The key vendors mentioned are Agilent Technologies, Inc., BGI Group, DNASTAR, Eurofins Scientific, Genedata AG, QIAGEN N.V., Illumina, Inc., NeoGenomics Laboratories, Perkin Elmer, Inc., GENEWIZ, Quest Diagnostics, Inc., Seven Bridges Genomics Inc., Thermo Fisher Scientific, Inc., Waters Corporation and Geneva Bioinformatics.
Product & Services Covered:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook